Carl Byrnes
Stock Analyst at Northland Capital Markets
(2.38)
# 2,593
Out of 4,984 analysts
25
Total ratings
50%
Success rate
11.76%
Average return
Main Sectors:
Stocks Rated by Carl Byrnes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNWV SANUWAVE Health | Initiates: Outperform | $55 | $34.10 | +61.29% | 1 | Sep 3, 2025 | |
| BWAY BrainsWay | Maintains: Outperform | $15 → $19 | $16.89 | +12.49% | 4 | Aug 14, 2025 | |
| BLFS BioLife Solutions | Maintains: Outperform | $28 → $31 | $25.98 | +19.32% | 2 | Jan 8, 2025 | |
| TLSI TriSalus Life Sciences | Initiates: Outperform | $13 | $4.73 | +164.27% | 1 | Oct 25, 2024 | |
| MDAI Spectral AI | Initiates: Outperform | $6 | $2.06 | +191.26% | 1 | Aug 12, 2024 | |
| COCH Envoy Medical | Initiates: Outperform | n/a | $1.34 | - | 1 | Dec 21, 2023 | |
| AMRN Amarin Corporation | Maintains: Market Perform | $40 → $25 | $14.93 | +67.45% | 1 | Jul 19, 2023 | |
| CDIO Cardio Diagnostics Holdings | Initiates: Outperform | $240 | $3.89 | +6,072.84% | 1 | May 22, 2023 | |
| VTVT vTv Therapeutics | Maintains: Outperform | $60 → $80 | $21.18 | +277.80% | 4 | Aug 17, 2022 | |
| MDXG MiMedx Group | Initiates: Outperform | $23 | $6.97 | +229.99% | 3 | Jul 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $30 → $24 | $2.77 | +766.43% | 4 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $2,000 | $2.34 | +85,370.09% | 1 | Oct 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.24 | - | 1 | Sep 27, 2017 |
SANUWAVE Health
Sep 3, 2025
Initiates: Outperform
Price Target: $55
Current: $34.10
Upside: +61.29%
BrainsWay
Aug 14, 2025
Maintains: Outperform
Price Target: $15 → $19
Current: $16.89
Upside: +12.49%
BioLife Solutions
Jan 8, 2025
Maintains: Outperform
Price Target: $28 → $31
Current: $25.98
Upside: +19.32%
TriSalus Life Sciences
Oct 25, 2024
Initiates: Outperform
Price Target: $13
Current: $4.73
Upside: +164.27%
Spectral AI
Aug 12, 2024
Initiates: Outperform
Price Target: $6
Current: $2.06
Upside: +191.26%
Envoy Medical
Dec 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $1.34
Upside: -
Amarin Corporation
Jul 19, 2023
Maintains: Market Perform
Price Target: $40 → $25
Current: $14.93
Upside: +67.45%
Cardio Diagnostics Holdings
May 22, 2023
Initiates: Outperform
Price Target: $240
Current: $3.89
Upside: +6,072.84%
vTv Therapeutics
Aug 17, 2022
Maintains: Outperform
Price Target: $60 → $80
Current: $21.18
Upside: +277.80%
MiMedx Group
Jul 26, 2021
Initiates: Outperform
Price Target: $23
Current: $6.97
Upside: +229.99%
May 5, 2021
Maintains: Market Perform
Price Target: $30 → $24
Current: $2.77
Upside: +766.43%
Oct 22, 2018
Initiates: Outperform
Price Target: $2,000
Current: $2.34
Upside: +85,370.09%
Sep 27, 2017
Initiates: Outperform
Price Target: n/a
Current: $1.24
Upside: -